| Maria Teresa Tam, MD | |
|
2845 N Sheridan Rd, Ste 902, Chicago, IL 60657-7227 | |
| (773) 904-8641 | |
| (872) 888-1206 |
| Full Name | Maria Teresa Tam |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 2845 N Sheridan Rd, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003843517 | NPI | - | NPPES |
| 036093565 | Medicaid | IL | |
| 1620171 | Other | IL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036093565 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presence Saint Joseph Hospital - Chicago | Chicago, IL | Hospital |
| Entity Name | Thorek Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643961 PECOS PAC ID: 4981593399 Enrollment ID: O20040313000143 |
News Archive
In a paper recently uploaded to the preprint server bioRxiv* by Diffley et al. (April 8th, 2021), inhibitors of one essential SARS-CoV-2 non-structural protein are explored, with four compounds, in particular, identified as potential antiviral leads that exhibit synergistic effects with antiviral drug remdesivir.
A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.
Researchers have shown that a Western diet may affect viral replication, disease severity, and immune protection following infection with SARS-CoV-2.
Repros Therapeutics Inc. today reported it has received Institutional Review Board (IRB) approval to commence the Phase IIb study of Androxal® in men with secondary hypogonadism. The Company has submitted the protocol for FDA comment and plans to begin enrolling subjects in January. Depending on the rate of subject enrollment, Repros hopes to have the study completed before the end of 2011.
Medical researchers at the University of Alberta studied the records of nearly 1000 patients who were admitted to hospital with pneumonia and noted those who were obese were more apt to survive compared to those who were of normal weight.
› Verified 3 days ago
| Entity Name | All For Women Healthcare Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417392408 PECOS PAC ID: 8325280530 Enrollment ID: O20130816000371 |
News Archive
In a paper recently uploaded to the preprint server bioRxiv* by Diffley et al. (April 8th, 2021), inhibitors of one essential SARS-CoV-2 non-structural protein are explored, with four compounds, in particular, identified as potential antiviral leads that exhibit synergistic effects with antiviral drug remdesivir.
A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.
Researchers have shown that a Western diet may affect viral replication, disease severity, and immune protection following infection with SARS-CoV-2.
Repros Therapeutics Inc. today reported it has received Institutional Review Board (IRB) approval to commence the Phase IIb study of Androxal® in men with secondary hypogonadism. The Company has submitted the protocol for FDA comment and plans to begin enrolling subjects in January. Depending on the rate of subject enrollment, Repros hopes to have the study completed before the end of 2011.
Medical researchers at the University of Alberta studied the records of nearly 1000 patients who were admitted to hospital with pneumonia and noted those who were obese were more apt to survive compared to those who were of normal weight.
› Verified 3 days ago
| Entity Name | Community First Healthcare Of Illinois Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881059897 PECOS PAC ID: 2860716685 Enrollment ID: O20160104001552 |
News Archive
In a paper recently uploaded to the preprint server bioRxiv* by Diffley et al. (April 8th, 2021), inhibitors of one essential SARS-CoV-2 non-structural protein are explored, with four compounds, in particular, identified as potential antiviral leads that exhibit synergistic effects with antiviral drug remdesivir.
A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.
Researchers have shown that a Western diet may affect viral replication, disease severity, and immune protection following infection with SARS-CoV-2.
Repros Therapeutics Inc. today reported it has received Institutional Review Board (IRB) approval to commence the Phase IIb study of Androxal® in men with secondary hypogonadism. The Company has submitted the protocol for FDA comment and plans to begin enrolling subjects in January. Depending on the rate of subject enrollment, Repros hopes to have the study completed before the end of 2011.
Medical researchers at the University of Alberta studied the records of nearly 1000 patients who were admitted to hospital with pneumonia and noted those who were obese were more apt to survive compared to those who were of normal weight.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Teresa Tam, MD 2845 N Sheridan Rd, Suite 902, Chicago, IL 60657-7227 Ph: (773) 904-8641 | Maria Teresa Tam, MD 2845 N Sheridan Rd, Ste 902, Chicago, IL 60657-7227 Ph: (773) 904-8641 |
News Archive
In a paper recently uploaded to the preprint server bioRxiv* by Diffley et al. (April 8th, 2021), inhibitors of one essential SARS-CoV-2 non-structural protein are explored, with four compounds, in particular, identified as potential antiviral leads that exhibit synergistic effects with antiviral drug remdesivir.
A new discovery by University of Guelph researchers may ultimately help in devising new therapies and improving quality of life for people with Parkinson's disease.
Researchers have shown that a Western diet may affect viral replication, disease severity, and immune protection following infection with SARS-CoV-2.
Repros Therapeutics Inc. today reported it has received Institutional Review Board (IRB) approval to commence the Phase IIb study of Androxal® in men with secondary hypogonadism. The Company has submitted the protocol for FDA comment and plans to begin enrolling subjects in January. Depending on the rate of subject enrollment, Repros hopes to have the study completed before the end of 2011.
Medical researchers at the University of Alberta studied the records of nearly 1000 patients who were admitted to hospital with pneumonia and noted those who were obese were more apt to survive compared to those who were of normal weight.
› Verified 3 days ago
Elizabeth Isak, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr Ste 810, Chicago, IL 60611 Phone: 312-926-8811 Fax: 312-926-8855 | |
Sonali Gupta, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1653 W Congress Pkwy, Chicago, IL 60612 Phone: 312-942-5000 | |
Malavika Kalyani Perinchery, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 5841 S Maryland Ave # Mc2050, Chicago, IL 60637 Phone: 773-834-0598 | |
Mr. Clyde Harris Lawson, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 8234 S. Ashland Avenue, Chicago, IL 60620 Phone: 773-874-1400 Fax: 773-874-9245 | |
Rebekah Osgood, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 680 N Lake Shore Dr Ste 810, Chicago, IL 60611 Phone: 312-926-3627 Fax: 312-587-9802 | |
Dr. Sarah Hoque, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2001 S California Ave, Chicago, IL 60608 Phone: 773-584-6200 |